NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma
Xin Yu,Lijun Xu,Yongqiang Zhou,Xiaorong Zhou,Lei Yang,Yan Zhou
DOI: https://doi.org/10.2147/jir.s426277
IF: 4.5
2023-08-29
Journal of Inflammation Research
Abstract:Xin Yu, 1, &ast Lijun Xu, 2, &ast Yongqiang Zhou, 3 Xiaorong Zhou, 4 Lei Yang, 2 Yan Zhou 1 1 Department of Orthodontics and Periodontology, Affiliated Nantong Stomatological Hospital of Nantong University, Nantong, People's Republic of China; 2 Department of Clinical Biobank & Institute of Oncology, Affiliated Hospital of Nantong University & Medical School of Nantong University, Nantong, People's Republic of China; 3 Department of Oral and Maxillofacial Surgery, Affiliated Nantong Stomatological Hospital of Nantong University, Nantong, People's Republic of China; 4 Department of Immunology, School of Medicine, Nantong University, Nantong, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan Zhou, Affiliated Nantong Stomatological Hospital of Nantong University, Nantong, 226001, People's Republic of China, Tel +86 513-89898899, Fax +86 513-89898890, Email Lei Yang, Affiliated Hospital of Nantong University & Medical School of Nantong University, Nantong, 226001, People's Republic of China, Tel +86 513-85052806, Email Background: Oral squamous cell carcinoma (OSCC) is the most common head and neck malignancy with a high mortality rate and poor prognosis. The exploration and understanding of biomarkers will help to further improve the diagnosis and treatment of OSCC. Methods: Tumor tissue samples from 319 OSCC patients were retrospectively collected, along with their clinical information. In combination with bioinformatics tools and multiplex immunohistochemistry (mIHC) analyses, we evaluated NUP62CL protein expression and its relationship to tumor-infiltrating immune cells (TIICs) and immune checkpoints in the tumor microenvironment (TME), as well as its association with clinical features and prognosis of OSCC. Results: We identified high-NUP62CL expression in OSCC tissues, and high-NUP62CL protein expression was associated with large tumor size, advanced clinical stage and poor prognosis. In addition, NUP62CL protein expression was positively associated with the abundance of CD3+CD4+ T cells ( P < 0.01), CD3+CD8+ T cells ( P < 0.01), CD56+ NK cells ( P < 0.05), CD68+CD86+ macrophages ( P < 0.01) and CD68+CD163+ macrophages ( P < 0.01), as well as the immune checkpoints, including PD-1 ( P < 0.001), PD-L1 ( P < 0.001), and CTLA-4 ( P < 0.001) protein expression. Conclusion: In conclusion, NUP62CL could be an effective prognostic and immunological biomarker for OSCC patients. Keywords: oral squamous cell carcinoma, NUP62CL, mIHC, prognosis, tumor-infiltrating immune cells, biomarker Oral squamous cell carcinoma (OSCC) is the most common oral malignancy, which originates from oral epithelial cells and develops into carcinoma in situ. 1 The most common sites are the lips, tongue, palate, buccal mucosa, gums, floor of the mouth, vestibule, and posterior molars. 2 Oral tissue is the main organ for the human body to eat and obtain nutrients. Chewing betel nut, chewing tobacco and irritation of tooth stump are the reasons for the high incidence of OSCC, which will hinder human nutrition intake through the oral pathway and lead to high mortality. 3 Globally, there will be 377,713 new cases and 177,757 deaths in 2020. 4,5 Although great progress has been made in the diagnosis and treatment of OSCC in recent years, the prognosis for OSCC has not improved significantly. According to clinical data, the 5-year survival rate of patients is about 50%. 6 Therefore, the exploration and understanding of biomarkers for OSCC will help to further improve the diagnosis and treatment of OSCC. Recently, Tumor microenvironment (TME), an environment for tumor occurrence, as the focus of current research, plays a key role in tumor progression. 7,8 Tumor-infiltrating immune cells (TIICs) are important regulatory factors in TME, which can either anti-tumor or promote tumor occurrence. 9 Studies have shown that TIICs are potential prognostic indicators of head and neck squamous cell carcinoma (HNSC). 10 Immune checkpoint molecules, commonly known as programmed cell death receptor 1 (PD-1) and its ligand programmed cell death ligand 1 (PD-L1), induce immunosuppression and protect tumors from immune attack. 11 Immunotherapy can activate the host's natural defense system and transform TME from tumor friendly to tumor suppressor, which is a very promising new strategy for cancer treatment. 12 The NUP family has been observed to play an important role in mitochondrial transport, DNA -Abstract Truncated-
immunology